<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Cytogenet</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Cytogenet</journal-id>
<journal-title-group>
<journal-title>Molecular Cytogenetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1755-8166</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31890032</article-id>
<article-id pub-id-type="pmc">6924070</article-id>
<article-id pub-id-type="publisher-id">467</article-id>
<article-id pub-id-type="doi">10.1186/s13039-019-0467-8</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Hypothesis</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The variome concept: focus on CNVariome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4134-8367</contrib-id>
<name>
<surname>Iourov</surname>
<given-names>Ivan Y.</given-names>
</name>
<address>
<email>ivan.iourov@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vorsanova</surname>
<given-names>Svetlana G.</given-names>
</name>
<address>
<email>svorsanova@mail.ru</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yurov</surname>
<given-names>Yuri B.</given-names>
</name>
<address>
<email>y_yurov@yahoo.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label>Yurov’s Laboratory of Molecular Genetics and Cytogenomics of the Brain, Mental Health Research Center, 117152 Moscow, Russia </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9216 2496</institution-id><institution-id institution-id-type="GRID">grid.415738.c</institution-id><institution>Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University, </institution><institution>Ministry of Health of Russian Federation, </institution></institution-wrap>125412 Moscow, Russia </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>19</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>19</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>12</volume>
<elocation-id>52</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>11</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>12</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Variome may be used for designating complex system of interplay between genomic variations specific for an individual or a disease. Despite the recognized complexity of genomic basis for phenotypic traits and diseases, studies of genetic causes of a disease are usually dedicated to the identification of single causative genomic changes (mutations). When such an artificially simplified model is employed, genomic basis of phenotypic outcomes remains elusive in the overwhelming majority of human diseases. Moreover, it is repeatedly demonstrated that multiple genomic changes within an individual genome are likely to underlie the phenome. Probably the best example of cumulative effect of variome on the phenotype is CNV (copy number variation) burden. Accordingly, we have proposed a variome concept based on CNV studies providing the evidence for the existence of a CNVariome (the set of CNV affecting an individual genome), a target for genomic analyses useful for unraveling genetic mechanisms of diseases and phenotypic traits.</p>
</sec>
<sec>
<title>Conclusion</title>
<p id="Par2">Variome (CNVariome) concept suggests that a genomic milieu is determined by the whole set of genomic variations (CNV) within an individual genome. The genomic milieu is likely to result from interplay between these variations. Furthermore, such kind of variome may be either individual or disease-specific. Additionally, such variome may be pathway-specific. The latter is able to affect molecular/cellular pathways of genome stability maintenance leading to occurrence of genomic/chromosome instability and/or somatic mosaicism resulting in somatic variome. This variome type seems to be important for unraveling disease mechanisms, as well. Finally, it appears that bioinformatic analysis of both individual and somatic variomes in the context of diseases- and pathway-specific variomes is the most promising way to determine genomic basis of the phenome and to unravel disease mechanisms for the management and treatment of currently incurable diseases.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Copy number variations</kwd>
<kwd>Genome variations</kwd>
<kwd>Pathways</kwd>
<kwd>Somatic mosaicism</kwd>
<kwd>Variome</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002261</institution-id>
<institution>Российский Фонд Фундаментальных Исследований (РФФИ)</institution>
</institution-wrap>
</funding-source>
<award-id>18-515-34005</award-id>
<principal-award-recipient>
<name>
<surname>Vorsanova</surname>
<given-names>Svetlana G.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p id="Par9">
<disp-quote><p id="Par10">
<italic>— You should always count everything, because everything counts.</italic>
</p><p id="Par11">
<italic>Raymond M. Smullyan</italic>
</p><p id="Par12">
<italic>(Alice in Puzzle-Land —</italic>
</p><p id="Par13">
<italic>A Carrollian Tale for Children under Eighty)</italic>
</p></disp-quote>
</p>
<p id="Par14">Variome is a term, which is generally used in the context of The Human Variome Project dedicated to collecting and integrating genomic data for the identification of disease-causing genome variations [<xref ref-type="bibr" rid="CR1">1</xref>]. On the other hand, variome may be defined as a complete (near-complete) set of genomic variations in an individual (individual variome or V<sub>i</sub>). Alternatively, a set of genomic variations associated with specific phenotypic traits or disease/condition may be described as a trait-specific or disease-specific variome (V<sub>ds</sub>). Actually, almost all relevant studies of disease-causing genetic changes in the whole genomic context might be designated as “variome analysis”, inasmuch as these studies are targeted at uncovering the whole set of genomic variations associated with a specific phenotype. For instance, genome-wide association studies (GWAS) is a picturesque, albeit not always successful, example of establishing V<sub>ds</sub> or the variome specific for a phenotypic trait/condition at the sequence level. Roughly, one can subdivide a general variome (V<sub>i</sub> or V<sub>ds</sub>) into two large distinct “variomic subtypes”: sequence variome (all the genomic variations detectable at the sequence level) and variome encompassing all the copy number variations (CNVs) or “CNVariome” adding balanced/imbalanced chromosome rearrangements and chromosomal heteromorphisms. Here, we focus on CNVariome to present the variome concept, which is able to become a useful system for high-throughput analysis of the functional consequences of individual and disease-specific genomic variability.</p>
<p id="Par15">CNVs have long been observed to contribute to genetic diversity in health and disease [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR5">5</xref>]. However, despite significant advances in CNV biology, difficulties in describing phenotypic outcome of both rare and common CNVs require an extensive bioinformatic analysis for identifying the pathogenic value (if any) of a genomic change from an individual CNVariome [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. An average individual genome exhibits myriads of sequence variants and hundreds of CNVs; bioinformatic analysis seems to be indispensable for evaluating each variant for defining the contribution to the phenotype [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. To succeed in gene/CNV prioritization or systems biology (OMICS/pathway-based) analysis, a big data analysis of genomic variations performed at genomic, epigenetic, proteomic and metabolome levels is applied [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>]. Moreover, recent studies have shown that CNVs are able to interact between each other within V<sub>i</sub> in a complex and multilateral fashion [<xref ref-type="bibr" rid="CR13">13</xref>]. Therefore, systems biology analyses of genomic variations suggest that causative variants are not isolated. Indeed, since genome variations are able to either increase or decrease the effect of each other, V<sub>i</sub> may be considered as a kind of “genomic milieu” for disease-causing (trait-associated) variations.</p>
<p id="Par16">The assumption that CNVariome is a genomic milieu modulating functional effects of CNVs may be further supported by the observation on the so-called “CNV burden” (a fraction of CNVs in an individual genome with appreciable functional consequences) [<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref>], which perfectly fits the variome concept or, more exactly, the CNVariome concept. Furthermore, experimental testing of two- and multiple-hit hypothesis has formed a firm basis for the CNVariome concept. According to the hypothesis, CNVs are able to increase or decrease gene dosage creating a genomic background or milieu (the first hit). This milieu is highly sensible to subsequent “second hit” or “multiple hits” (i.e. sporadic mutations, somatic mosaicism or chromosome/genome instability), which produces specific phenotypes [<xref ref-type="bibr" rid="CR17">17</xref>–<xref ref-type="bibr" rid="CR20">20</xref>]. Therefore, to define the genomic milieu created by CNVariome, it is to address all detectable CNVs in an individual genome. These data would be important for the definition of V<sub>ds</sub>, as well.</p>
<p id="Par17">The phenotypic effect of genomic variations is achieved through the impact on specific molecular and cellular pathways. Although the spectrum of functional consequences of genomic variations seems to be extremely broad, it is generally acknowledged that an effect (even if it is low) on molecular pathways/processes does exist [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR21">21</xref>–<xref ref-type="bibr" rid="CR23">23</xref>]. Additionally, common variants are able to possess functional effects at the protein level [<xref ref-type="bibr" rid="CR22">22</xref>]. Therefore, to address genomic variations’ impact on molecular pathways, one has to take into account the whole set of variants detected in an individual genome or, in other words, one has to analyze the variome. As to CNVs (CNVariome), our previous studies have shown that both common CNVs with a slight functional effect on a pathway (e.g. CNVs affecting genes involved in the cell cycle pathway) are able to cause chromosome instability detectable by cytogenetic analysis [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Similar results have been reported in studies of variome at the sequence level in health and disease highlighting new genomic mechanisms for interindividual diversity achieved through the functional variation in molecular pathways [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. More importantly, it is suggested that such genomic variations contribute to intercellular functional diversity, as well [<xref ref-type="bibr" rid="CR28">28</xref>–<xref ref-type="bibr" rid="CR30">30</xref>]. Genome variability/instability in cancer is probably the best example of how multiple chromosome abnormalities, CNVs and/or gene mutations may lead to dramatic functional changes of molecular and cellular pathways [<xref ref-type="bibr" rid="CR31">31</xref>–<xref ref-type="bibr" rid="CR33">33</xref>]. Actually, single-cell systems biology analyses have shown that such pathway changes mediated by genomic variations do occur [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Therefore, it is useful to introduce another “variomic subtype”, i.e. pathway-specific variome(s) (V<sub>ps</sub>) covering the set of genomic variations affecting specific pathway. Thus, V<sub>i</sub> or V<sub>ds</sub> appears to be composed of a number of V<sub>ps</sub>. Taking into account how CNVs functionally affect molecular and cellular pathways mediating the phenotypic outcome [<xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR37">37</xref>], one can suggest that appreciable effects of V<sub>ps</sub> are likely to be the result of a number of variants that affects the pathway. In other words, the effect results from a kind of saturation in genomic variations or in CNVs. Figure <xref ref-type="fig" rid="Fig1">1</xref> schematically depicts the variome (CNVariome) concept in the light of functional effects of genomic variations on molecular and cellular pathways.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Schematic representation of the variome (CNVariome) concept; a set of genomic variations (e.g. CNV) may contribute to functional variability of molecular/cellular pathways or create several V<sub>ps</sub> symbolically depicted as colored laboratory tubes; when the number of genomic variations achieves a critical level (i.e. saturation in genomic variations), an alteration to the pathway occurs (e.g. left-most and right-most tubes). A screenshot of CNV analysis by Chromosome Analysis Suite (ChAS) 3.10.15© 2015 Affymetrix Inc. was used to depict individual variome (CNVariome)</p></caption><graphic id="MO1" xlink:href="13039_2019_467_Fig1_HTML"></graphic></fig></p>
<p id="Par18">Molecular pathways are the intermediate link between the genome and the phenome [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Moreover, the pathways are promising targets for molecular-oriented therapy in diseases associated with genomic pathology (i.e. chromosomal abnormalities and CNVs) [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR38">38</xref>–<xref ref-type="bibr" rid="CR40">40</xref>]. Therefore, the identification of V<sub>ps</sub> or decomposition of V<sub>i</sub>/V<sub>ds</sub> into a set of V<sub>ps</sub> would be useful for unraveling disease mechanisms to develop effective management and treatment of currently incurable genetic diseases.</p>
<p id="Par19">An important aspect of genomic variability is referred to somatic genome variations or somatic mosaicism. Indeed, this phenomenon reflect an important, albeit commonly overlooked, ability of genome (cellular genomes) to vary through ontogeny [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Somatic mutations cause cancer [<xref ref-type="bibr" rid="CR31">31</xref>–<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Somatic mosaicism has been consistently associated with interindividual/intercellular genomic heterogeneity in health and disease [<xref ref-type="bibr" rid="CR43">43</xref>–<xref ref-type="bibr" rid="CR45">45</xref>]. More precisely, neurodevelopmental diseases have been repeatedly associated with chromosomal mosaicism and mosaic CNVs/gene mutations [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR46">46</xref>–<xref ref-type="bibr" rid="CR49">49</xref>]. Chromosomal mosaicism and instability has been demonstrated to mediate neurodegeneration [<xref ref-type="bibr" rid="CR48">48</xref>–<xref ref-type="bibr" rid="CR57">57</xref>]. Further studies have indicated that chromosome instability is an important element of a pathogenic cascade of neurodegenerative diseases [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR54">54</xref>–<xref ref-type="bibr" rid="CR57">57</xref>]. Therefore, to address genomic (genetic) mechanisms for human diseases in their complexity, it is unavoidable to consider somatic genome variations. In the light of the variome concept, we introduce the somatic variome (V<sub>s</sub>), which may be defined as a set of somatic genome variations (somatic mosaicism + genomic and chromosomal instability) detected in an individual. Somatic mosaicism and genomic/chromosomal instability are likely to occur due to altered molecular/cellular pathways controlling genome stability maintenance, cell cycle and programmed cell death [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. We hypothesize that a set of V<sub>ps</sub> of these pathways is able to produce a kind of susceptibility of cellular genomes to genomic/chromosomal instability and/or somatic mosaicism. Therefore, systems biology analyses of V<sub>i</sub> and molecular cytogenetic survey of chromosome/genome instability may identify the link between non-mosaic (germline inherited/sporadic) and somatic genome variations. Figure <xref ref-type="fig" rid="Fig2">2</xref> shows the interplay between V<sub>i</sub> and V<sub>s</sub> according to the concept. The result of addressing the interplay between V<sub>i</sub> and V<sub>s</sub> might be a “constitutional variome”, which might be basic genomic background of all the somatic cells evolved/developed from single zygote encompassing acquired somatic mutations in different tissues produced by genetic-environmental interactions and ontogenetic genome variations. The “constitutional variome” might represent a complex system of interactions between the whole set of individual and intercellular genome variations uniquely describing the intrinsic genomic milieu of an individual. The genomic milieu should reflect the whole burden of genomic variations including individual combinations of inherited variants, which are able to modulate the phenotype (i.e. reduced penetrance or increased severity of disease manifestations and phenotypic traits) or, in other words, to form an “inheritance pattern” applicable not only to monogenic diseases, but also to multifactorial disorders in a threshold manner as shown in Fig. <xref ref-type="fig" rid="Fig1">1</xref>.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Interplay between V<sub>i</sub> and V<sub>s</sub>; CNVariome and sequence variome forming V<sub>i</sub> may alter pathways critical for maintaining genome stability, cell cycle, and/or programmed cell death; the result of such alterations is likely to be a susceptibility for specific V<sub>s</sub>, which encompass somatic mosacism as well as chromosome and genome instability</p></caption><graphic id="MO2" xlink:href="13039_2019_467_Fig2_HTML"></graphic></fig></p>
<p id="Par20">The variome concept proposes that functional variability of molecular/cellular pathways determining the phenome is the result of the effect of all the variants of an individual genome (variome). The effects can be cumulative, interchangeable, mutually exclusive or neutral. However, one should bear in mind that the whole V<sub>i</sub>/V<sub>ds</sub> should be addressed to determine the intrinsic effect. In the genomic context, V<sub>i</sub> and V<sub>ds</sub> are composed of two variome subtypes: sequence variome and CNVariome. In the functional genomic context, V<sub>i</sub> /V<sub>ds</sub> may be decomposed into a set of V<sub>ps</sub>. In the (molecular) cytogenetic context, the CNVariome concept suggests that the individual uniqueness at molecular and cellular levels may result from an individual set of CNVs (in addition to sequence variome). If V<sub>i</sub>/V<sub>ds</sub> is enriched in V<sub>ps</sub> of genome stability maintenance, cell cycle, and programmed cell death, a susceptibility to genomic/chromosomal instability and/or somatic mosaicism may occur. Accordingly, V<sub>s</sub> should be addressed in addition to V<sub>i</sub>/V<sub>ds</sub> for comprehensive evaluation of the whole spectrum of genomic changes contributing to the phenome. Since the famous quote “Ontogeny recapitulates phylogeny” from Ernst Haeckel’s classic works remains more-or-less actual [<xref ref-type="bibr" rid="CR58">58</xref>–<xref ref-type="bibr" rid="CR60">60</xref>], variome concept encompassing V<sub>i</sub>/V<sub>ds</sub>, V<sub>ps</sub> and V<sub>s</sub> seems to applicable in the evolutionary context, as well, allowing us to finalize description of the concept by another famous quotation “Nothing in biology makes sense except in the light of evolution” from Theodosius Dobzhansky [<xref ref-type="bibr" rid="CR61">61</xref>]. To this end, we believe that the concept is able to provide a valuable system for determining the genomic basis of the phenome and for unravel disease mechanisms to succeed in the management and treatment of currently incurable genetic diseases.</p>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>CNVs</term>
<def>
<p id="Par3">Copy number variations</p>
</def>
</def-item>
<def-item>
<term>GWAS</term>
<def>
<p id="Par4">Genome-wide association studies</p>
</def>
</def-item>
<def-item>
<term>V<sub>ds</sub></term>
<def>
<p id="Par5">Disease-specific variome</p>
</def>
</def-item>
<def-item>
<term>V<sub>i</sub></term>
<def>
<p id="Par6">Individual variome</p>
</def>
</def-item>
<def-item>
<term>V<sub>ps</sub></term>
<def>
<p id="Par7">Pathway-specific variome</p>
</def>
</def-item>
<def-item>
<term>V<sub>s</sub></term>
<def>
<p id="Par8">Somatic variome</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisher’s Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<ack>
<p>Not applicable.</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>IYI conceived the core idea of the concept and wrote the manuscript. SGV and YBY made significant theoretic contribution. All authors have read and approved the final manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>Professors SG Vorsanova and IY Iourov are partially supported by RFBR and CITMA according to the research project No. 18–515-34005. Prof. IY Iourov is supported by the Government Assignment of the Russian Ministry of Science and Higher Education, Assignment no. AAAA-A19–119040490101-6. Prof. SG Vorsanova is supported by the Government Assignment of the Russian Ministry of Health, Assignment no. AAAA-A18–118051590122-7.</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>Not applicable.</p>
</notes>
<notes>
<title>Ethics approval and consent to participate</title>
<p id="Par21">Not applicable.</p>
</notes>
<notes>
<title>Consent for publication</title>
<p id="Par22">Not applicable.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par23">The authors declare that they have no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burn</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The human Variome project</article-title>
<source/>Hum Mutat
          <year>2016</year>
<volume>37</volume>
<issue>6</issue>
<fpage>505</fpage>
<lpage>507</lpage>
<pub-id pub-id-type="doi">10.1002/humu.22986</pub-id>
<pub-id pub-id-type="pmid">26987309</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Iafrate</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Brothman</surname>
<given-names>AR</given-names>
</name>
</person-group>
<article-title>Copy number variations and clinical cytogenetic diagnosis of constitutional disorders</article-title>
<source/>Nat Genet
          <year>2007</year>
<volume>39</volume>
<issue>7 Suppl</issue>
<fpage>S48</fpage>
<lpage>S54</lpage>
<pub-id pub-id-type="doi">10.1038/ng2092</pub-id>
<pub-id pub-id-type="pmid">17597782</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
</person-group>
<article-title>Molecular cytogenetics and cytogenomics of brain diseases</article-title>
<source/>Curr Genomics
          <year>2008</year>
<volume>9</volume>
<issue>7</issue>
<fpage>452</fpage>
<lpage>465</lpage>
<pub-id pub-id-type="doi">10.2174/138920208786241216</pub-id>
<pub-id pub-id-type="pmid">19506734</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hochstenbach</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Buizer-Voskamp</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Vorstman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Ophoff</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research</article-title>
<source/>Cytogenet Genome Res
          <year>2011</year>
<volume>135</volume>
<issue>3–4</issue>
<fpage>174</fpage>
<lpage>202</lpage>
<pub-id pub-id-type="doi">10.1159/000332928</pub-id>
<pub-id pub-id-type="pmid">22056632</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zarrei</surname>
<given-names>M</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Merico</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>A copy number variation map of the human genome</article-title>
<source/>Nat Rev Genet
          <year>2015</year>
<volume>16</volume>
<issue>3</issue>
<fpage>172</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3871</pub-id>
<pub-id pub-id-type="pmid">25645873</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacArthur</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Manolio</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Dimmock</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Rehm</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Abecasis</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Altman</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Antonarakis</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Ashley</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Biesecker</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Conrad</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Gerstein</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Hirschhorn</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Leal</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Pennacchio</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Stamatoyannopoulos</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Sunyaev</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Valle</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Voight</surname>
<given-names>BF</given-names>
</name>
<name>
<surname>Winckler</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gunter</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Guidelines for investigating causality of sequence variants in human disease</article-title>
<source/>Nature
          <year>2014</year>
<volume>508</volume>
<issue>7497</issue>
<fpage>469</fpage>
<lpage>476</lpage>
<pub-id pub-id-type="doi">10.1038/nature13127</pub-id>
<pub-id pub-id-type="pmid">24759409</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
</person-group>
<article-title>In silico molecular cytogenetics: a bioinformatic approach to prioritization of candidate genes and copy number variations for basic and clinical genome research</article-title>
<source/>Mol Cytogenet
          <year>2014</year>
<volume>7</volume>
<issue>1</issue>
<fpage>98</fpage>
<pub-id pub-id-type="doi">10.1186/s13039-014-0098-z</pub-id>
<pub-id pub-id-type="pmid">25525469</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Sham</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Genetic variant representation, annotation and prioritization in the post-GWAS era</article-title>
<source/>Cell Res
          <year>2012</year>
<volume>22</volume>
<issue>10</issue>
<fpage>1505</fpage>
<lpage>1508</lpage>
<pub-id pub-id-type="doi">10.1038/cr.2012.106</pub-id>
<pub-id pub-id-type="pmid">22801476</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suwinski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>MHT</given-names>
</name>
<name>
<surname>Poh</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>HS</given-names>
</name>
</person-group>
<article-title>Advancing personalized medicine through the application of whole exome sequencing and big data analytics</article-title>
<source/>Front Genet
          <year>2019</year>
<volume>10</volume>
<fpage>49</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2019.00049</pub-id>
<pub-id pub-id-type="pmid">30809243</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Linghu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Snitkin</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Delisi</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Genome-wide prioritization of disease genes and identification of disease-disease associations from an integrated human functional linkage network</article-title>
<source/>Genome Biol
          <year>2009</year>
<volume>10</volume>
<issue>9</issue>
<fpage>R91</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2009-10-9-r91</pub-id>
<pub-id pub-id-type="pmid">19728866</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HU</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SY</given-names>
</name>
</person-group>
<article-title>Current status and applications of genome-scale metabolic models</article-title>
<source/>Genome Biol
          <year>2019</year>
<volume>20</volume>
<issue>1</issue>
<fpage>121</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-019-1730-3</pub-id>
<pub-id pub-id-type="pmid">31196170</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
</person-group>
<article-title>Pathway-based classification of genetic diseases</article-title>
<source/>Mol Cytogenet
          <year>2019</year>
<volume>12</volume>
<fpage>4</fpage>
<pub-id pub-id-type="doi">10.1186/s13039-019-0418-4</pub-id>
<pub-id pub-id-type="pmid">30766616</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>An interaction-based model for neuropsychiatric features of copy-number variants</article-title>
<source/>PLoS Genet
          <year>2019</year>
<volume>15</volume>
<issue>1</issue>
<fpage>e1007879</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1007879</pub-id>
<pub-id pub-id-type="pmid">30653500</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brkanac</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vu</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Shafer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bernier</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ferrero</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Silengo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Fichera</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Raskind</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Relative burden of large CNVs on a range of neurodevelopmental phenotypes</article-title>
<source/>PLoS Genet
          <year>2011</year>
<volume>7</volume>
<issue>11</issue>
<fpage>e1002334</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1002334</pub-id>
<pub-id pub-id-type="pmid">22102821</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desachy</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Croen</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Kharrazi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Delorenze</surname>
<given-names>GN</given-names>
</name>
<name>
<surname>Windham</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>Increased female autosomal burden of rare copy number variants in human populations and in autism families</article-title>
<source/>Mol Psychiatry
          <year>2015</year>
<volume>20</volume>
<issue>2</issue>
<fpage>170</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2014.179</pub-id>
<pub-id pub-id-type="pmid">25582617</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aguirre</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rivas</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Priest</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Phenome-wide burden of copy-number variation in the UK biobank</article-title>
<source/>Am J Hum Genet
          <year>2019</year>
<volume>105</volume>
<issue>2</issue>
<fpage>373</fpage>
<lpage>383</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2019.07.001</pub-id>
<pub-id pub-id-type="pmid">31353025</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Phenotypic variability and genetic susceptibility to genomic disorders</article-title>
<source/>Hum Mol Genet
          <year>2010</year>
<volume>19</volume>
<issue>R2</issue>
<fpage>R176</fpage>
<lpage>R187</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddq366</pub-id>
<pub-id pub-id-type="pmid">20807775</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
</person-group>
<article-title>Somatic cell genomics of brain disorders: a new opportunity to clarify genetic-environmental interactions</article-title>
<source/>Cytogenet Genome Res
          <year>2013</year>
<volume>139</volume>
<issue>3</issue>
<fpage>181</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1159/000347053</pub-id>
<pub-id pub-id-type="pmid">23428498</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrews</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Honti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pfundt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>de Leeuw</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hehir-Kwa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vulto-van Silfhout</surname>
<given-names>A</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Webber</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The clustering of functionally related genes contributes to CNV-mediated disease</article-title>
<source/>Genome Res
          <year>2015</year>
<volume>25</volume>
<issue>6</issue>
<fpage>802</fpage>
<lpage>813</lpage>
<pub-id pub-id-type="doi">10.1101/gr.184325.114</pub-id>
<pub-id pub-id-type="pmid">25887030</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<mixed-citation publication-type="other">Vorsanova SG, Yurov YB, Iourov IY. Neurogenomic pathway of autism spectrum disorders: linking germline and somatic mutations to genetic-environmental interactions. Curr Bioinformatics. 2017;12(1):19–26.</mixed-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schadt</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Molecular networks as sensors and drivers of common human diseases</article-title>
<source/>Nature
          <year>2009</year>
<volume>461</volume>
<issue>7261</issue>
<fpage>218</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.1038/nature08454</pub-id>
<pub-id pub-id-type="pmid">19741703</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahlich</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Reeb</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hecht</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schelling</surname>
<given-names>M</given-names>
</name>
<name>
<surname>De Beer</surname>
<given-names>TAP</given-names>
</name>
<name>
<surname>Bromberg</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Rost</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Common sequence variants affect molecular function more than rare variants?</article-title>
<source/>Sci Rep
          <year>2017</year>
<volume>7</volume>
<issue>1</issue>
<fpage>1608</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-01054-2</pub-id>
<pub-id pub-id-type="pmid">28487536</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<mixed-citation publication-type="other">Li Y, McGrail DJ, Latysheva N, Yi S, Babu MM, Sahni N. Pathway perturbations in signaling networks: linking genotype to phenotype. Semin Cell Dev Biol. 2018. 10.1016/j.semcdb.2018.05.001.</mixed-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Zelenova</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Korostelev</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
</person-group>
<article-title>Genomic copy number variation affecting genes involved in the cell cycle pathway: implications for somatic mosaicism</article-title>
<source/>Int J Genomics
          <year>2015</year>
<volume>2015</volume>
<fpage>757680</fpage>
<pub-id pub-id-type="doi">10.1155/2015/757680</pub-id>
<pub-id pub-id-type="pmid">26421275</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<mixed-citation publication-type="other">Yurov YB, Iourov IY, Vorsanova SG. Network-based classification of molecular cytogenetic data. Curr Bioinformatics. 2017;12(1):27–33.</mixed-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bromberg</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Rost</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Neutral and weakly nonneutral sequence variants may define individuality</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2013</year>
<volume>110</volume>
<issue>35</issue>
<fpage>14255</fpage>
<lpage>14260</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1216613110</pub-id>
<pub-id pub-id-type="pmid">23940345</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Astrakhan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Schreiber</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bromberg</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Identifying Crohn’s disease signal from variome analysis</article-title>
<source/>Genome Med
          <year>2019</year>
<volume>11</volume>
<issue>1</issue>
<fpage>59</fpage>
<pub-id pub-id-type="doi">10.1186/s13073-019-0670-6</pub-id>
<pub-id pub-id-type="pmid">31564248</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
</person-group>
<article-title>Single cell genomics of the brain: focus on neuronal diversity and neuropsychiatric diseases</article-title>
<source/>Curr Genomics
          <year>2012</year>
<volume>13</volume>
<issue>6</issue>
<fpage>477</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="doi">10.2174/138920212802510439</pub-id>
<pub-id pub-id-type="pmid">23449087</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heng</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Horne</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Chaudhry</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Abdallah</surname>
<given-names>BY</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>A postgenomic perspective on molecular cytogenetics</article-title>
<source/>Curr Genomics
          <year>2018</year>
<volume>19</volume>
<issue>3</issue>
<fpage>227</fpage>
<lpage>239</lpage>
<pub-id pub-id-type="doi">10.2174/1389202918666170717145716</pub-id>
<pub-id pub-id-type="pmid">29606910</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hawe</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Theis</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Heinig</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Inferring interaction networks from multi-omics data</article-title>
<source/>Front Genet
          <year>2019</year>
<volume>10</volume>
<fpage>535</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2019.00535</pub-id>
<pub-id pub-id-type="pmid">31249591</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Heng</surname>
<given-names>HH</given-names>
</name>
</person-group>
<source/>Debating cancer: the paradox in cancer research
          <year>2015</year>
<publisher-loc>New Jersey</publisher-loc>
<publisher-name>World Scientific Publishing Company</publisher-name>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loeb</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>Human cancers express mutator phenotypes: origin, consequences and targeting</article-title>
<source/>Nat Rev Cancer
          <year>2011</year>
<volume>11</volume>
<issue>6</issue>
<fpage>450</fpage>
<lpage>457</lpage>
<pub-id pub-id-type="doi">10.1038/nrc3063</pub-id>
<pub-id pub-id-type="pmid">21593786</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fox</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Prindle</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Loeb</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>Do mutator mutations fuel tumorigenesis?</article-title>
<source/>Cancer Metastasis Rev
          <year>2013</year>
<volume>32</volume>
<issue>3–4</issue>
<fpage>353</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="doi">10.1007/s10555-013-9426-8</pub-id>
<pub-id pub-id-type="pmid">23592419</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frost</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Amos</surname>
<given-names>CI</given-names>
</name>
</person-group>
<article-title>A multi-omics approach for identifying important pathways and genes in human cancer</article-title>
<source/>BMC Bioinformatics
          <year>2018</year>
<volume>19</volume>
<issue>1</issue>
<fpage>479</fpage>
<pub-id pub-id-type="doi">10.1186/s12859-018-2476-8</pub-id>
<pub-id pub-id-type="pmid">30541428</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patange</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Girvan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Single-cell systems biology: probing the basic unit of information flow</article-title>
<source/>Curr Opin Syst Biol
          <year>2018</year>
<volume>8</volume>
<fpage>7</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1016/j.coisb.2017.11.011</pub-id>
<pub-id pub-id-type="pmid">29552672</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Parikh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Filipink</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>JS</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Angle</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Meschino</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Nezarati</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Asamoah</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Gowans</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Carmany</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Stockton</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Schnur</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Penney</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Raskin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Leppig</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Thiese</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Aberg</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Niyazov</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Escobar</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>El-Khechen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Lebel</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Siefkas</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shur</surname>
<given-names>N</given-names>
</name>
<name>
<surname>McGuire</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brasington</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Spence</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Clericuzio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ballif</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Phenotypic heterogeneity of genomic disorders and rare copy-number variants</article-title>
<source/>N Engl J Med
          <year>2012</year>
<volume>367</volume>
<issue>14</issue>
<fpage>1321</fpage>
<lpage>1331</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1200395</pub-id>
<pub-id pub-id-type="pmid">22970919</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
</person-group>
<article-title>Somatic genome variations in health and disease</article-title>
<source/>Curr Genomics
          <year>2010</year>
<volume>11</volume>
<issue>6</issue>
<fpage>387</fpage>
<lpage>396</lpage>
<pub-id pub-id-type="doi">10.2174/138920210793176065</pub-id>
<pub-id pub-id-type="pmid">21358982</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heng</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>A systems biology perspective on molecular cytogenetics</article-title>
<source/>Curr Bioinforma
          <year>2017</year>
<volume>12</volume>
<issue>1</issue>
<fpage>4</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.2174/1574893611666160606163419</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Voinova</surname>
<given-names>VY</given-names>
</name>
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
</person-group>
<article-title>3p22.1p21.31 microdeletion identifies CCK as Asperger syndrome candidate gene and shows the way for therapeutic strategies in chromosome imbalances</article-title>
<source/>Mol Cytogenet
          <year>2015</year>
<volume>8</volume>
<fpage>82</fpage>
<pub-id pub-id-type="doi">10.1186/s13039-015-0185-9</pub-id>
<pub-id pub-id-type="pmid">26523151</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
</person-group>
<article-title>Cytopostgenomics: what is it and how does it work?</article-title>
<source/>Curr Genomics
          <year>2019</year>
<volume>20</volume>
<issue>2</issue>
<fpage>77</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.2174/138920292002190422120524</pub-id>
<pub-id pub-id-type="pmid">31555057</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
</person-group>
<article-title>Ontogenetic variation of the human genome</article-title>
<source/>Curr Genomics
          <year>2010</year>
<volume>11</volume>
<issue>6</issue>
<fpage>420</fpage>
<lpage>425</lpage>
<pub-id pub-id-type="doi">10.2174/138920210793175958</pub-id>
<pub-id pub-id-type="pmid">21358986</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Stilgenbauer</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Moy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Heng</surname>
<given-names>HH</given-names>
</name>
</person-group>
<article-title>What is karyotype coding and why is genomic topology important for cancer and evolution?</article-title>
<source/>Front Genet
          <year>2019</year>
<volume>10</volume>
<fpage>1082</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2019.01082</pub-id>
<pub-id pub-id-type="pmid">31737054</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
</person-group>
<article-title>Chromosomal variation in mammalian neuronal cells: known facts and attractive hypotheses</article-title>
<source/>Int Rev Cytol
          <year>2006</year>
<volume>249</volume>
<fpage>143</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="doi">10.1016/S0074-7696(06)49003-3</pub-id>
<pub-id pub-id-type="pmid">16697283</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rohrback</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Siddoway</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Genomic mosaicism in the developing and adult brain</article-title>
<source/>Dev Neurobiol
          <year>2018</year>
<volume>78</volume>
<issue>11</issue>
<fpage>1026</fpage>
<lpage>1048</lpage>
<pub-id pub-id-type="doi">10.1002/dneu.22626</pub-id>
<pub-id pub-id-type="pmid">30027562</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>Ivan Y.</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>Svetlana G.</given-names>
</name>
<name>
<surname>Yurov</surname>
<given-names>Yuri B.</given-names>
</name>
<name>
<surname>Kutsev</surname>
<given-names>Sergei I.</given-names>
</name>
</person-group>
<article-title>Ontogenetic and Pathogenetic Views on Somatic Chromosomal Mosaicism</article-title>
<source/>Genes
          <year>2019</year>
<volume>10</volume>
<issue>5</issue>
<fpage>379</fpage>
<pub-id pub-id-type="doi">10.3390/genes10050379</pub-id>
<pub-id pub-id-type="pmid">6562967</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Demidova</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Beresheva</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Kravetz</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Monakhov</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Kolotii</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Voinova-Ulas</surname>
<given-names>VY</given-names>
</name>
<name>
<surname>Gorbachevskaya</surname>
<given-names>NL</given-names>
</name>
</person-group>
<article-title>Unexplained autism is frequently associated with low-level mosaic aneuploidy</article-title>
<source/>J Med Genet
          <year>2007</year>
<volume>44</volume>
<issue>8</issue>
<fpage>521</fpage>
<lpage>525</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2007.049312</pub-id>
<pub-id pub-id-type="pmid">17483303</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D'Gama</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Somatic mosaicism and neurodevelopmental disease</article-title>
<source/>Nat Neurosci
          <year>2018</year>
<volume>21</volume>
<issue>11</issue>
<fpage>1504</fpage>
<lpage>1514</lpage>
<pub-id pub-id-type="doi">10.1038/s41593-018-0257-3</pub-id>
<pub-id pub-id-type="pmid">30349109</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Liehr</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Mendez-Rosado</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
</person-group>
<article-title>The applicability of interphase chromosome-specific multicolor banding (ICS-MCB) for studying neurodevelopmental and neurodegenerative disorders</article-title>
<source/>Res Results Biomedicine
          <year>2019</year>
<volume>5</volume>
<issue>3</issue>
<fpage>4</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.18413/2658-6533-2019-5-3-0-1</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Potter</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chial</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Caneus</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Elos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Elder</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Borysov</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Granic</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Chromosome instability and mosaic aneuploidy in neurodegenerative and neurodevelopmental disorders</article-title>
<source/>Front Genet
          <year>2019</year>
<volume>10</volume>
<fpage>1092</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2019.01092</pub-id>
<pub-id pub-id-type="pmid">31788001</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Liehr</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kolotii</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
</person-group>
<article-title>Increased chromosome instability dramatically disrupts neural genome integrity and mediates cerebellar degeneration in the ataxia-telangiectasia brain</article-title>
<source/>Hum Mol Genet
          <year>2009</year>
<volume>18</volume>
<issue>14</issue>
<fpage>2656</fpage>
<lpage>2669</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddp207</pub-id>
<pub-id pub-id-type="pmid">19414482</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Liehr</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
</person-group>
<article-title>Aneuploidy in the normal, Alzheimer’s disease and ataxia-telangiectasia brain: differential expression and pathological meaning</article-title>
<source/>Neurobiol Dis
          <year>2009</year>
<volume>34</volume>
<issue>2</issue>
<fpage>212</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2009.01.003</pub-id>
<pub-id pub-id-type="pmid">19344645</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arendt</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Brückner</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Mosch</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lösche</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Selective cell death of hyperploid neurons in Alzheimer's disease</article-title>
<source/>Am J Pathol
          <year>2010</year>
<volume>177</volume>
<issue>1</issue>
<fpage>15</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.2353/ajpath.2010.090955</pub-id>
<pub-id pub-id-type="pmid">20472889</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
</person-group>
<article-title>Genomic landscape of the Alzheimer’s disease brain: chromosome instability — aneuploidy, but not tetraploidy — mediates neurodegeneration</article-title>
<source/>Neurodegener Dis
          <year>2011</year>
<volume>8</volume>
<issue>1–2</issue>
<fpage>35</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="pmid">21135562</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
</person-group>
<article-title>The DNA replication stress hypothesis of Alzheimer's disease</article-title>
<source/>Sci World J
          <year>2011</year>
<volume>11</volume>
<fpage>2602</fpage>
<lpage>2612</lpage>
<pub-id pub-id-type="doi">10.1100/2011/625690</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Granic</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Mitotic spindle defects and chromosome mis-segregation induced by LDL/cholesterol-implications for Niemann-pick C1, Alzheimer’s disease, and atherosclerosis</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<issue>4</issue>
<fpage>e60718</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0060718</pub-id>
<pub-id pub-id-type="pmid">23593294</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bajic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Spremo-Potparevic</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zivkovic</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Isenovic</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Arendt</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Cohesion and the aneuploid phenotype in Alzheimer's disease: a tale of genome instability</article-title>
<source/>Neurosci Biobehav Rev
          <year>2015</year>
<volume>55</volume>
<fpage>365</fpage>
<lpage>374</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2015.05.010</pub-id>
<pub-id pub-id-type="pmid">26003528</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
</person-group>
<article-title>Chromosome instability in the neurodegenerating brain</article-title>
<source/>Front Genet
          <year>2019</year>
<volume>10</volume>
<fpage>892</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2019.00892</pub-id>
<pub-id pub-id-type="pmid">31616475</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Haeckel</surname>
<given-names>E</given-names>
</name>
</person-group>
<source/>Generelle Morphologie der Organismen, 2 Bde
          <year>1866</year>
<publisher-loc>Berlin</publisher-loc>
<publisher-name>Georg Reimer</publisher-name>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohno</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Why ontogeny recapitulates phylogeny</article-title>
<source/>Electrophoresis
          <year>1995</year>
<volume>16</volume>
<issue>9</issue>
<fpage>1782</fpage>
<lpage>1786</lpage>
<pub-id pub-id-type="doi">10.1002/elps.11501601295</pub-id>
<pub-id pub-id-type="pmid">8582372</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olsson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Levit</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Hoßfeld</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>The “biogenetic law” in zoology: from Ernst Haeckel’s formulation to current approaches</article-title>
<source/>Theory Biosci
          <year>2017</year>
<volume>136</volume>
<issue>1–2</issue>
<fpage>19</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1007/s12064-017-0243-4</pub-id>
<pub-id pub-id-type="pmid">28224466</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dobzhansky</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Nothing in biology makes sense except in the light of evolution</article-title>
<source/>Am Biol Teach
          <year>2013</year>
<volume>75</volume>
<issue>2</issue>
<fpage>87</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1525/abt.2013.75.2.reprint</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>